{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T13:42:44Z","timestamp":1772026964416,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/bf03261962","type":"journal-article","created":{"date-parts":[[2013,1,7]],"date-time":"2013-01-07T05:15:56Z","timestamp":1357535756000},"page":"655-665","source":"Crossref","is-referenced-by-count":41,"title":["Workshop- and Telephone-Based Interventions to Improve Adverse Drug Reaction Reporting"],"prefix":"10.1007","volume":"35","author":[{"given":"Maria Teresa","family":"Herdeiro","sequence":"first","affiliation":[]},{"given":"In\u00eas","family":"Ribeiro-Vaz","sequence":"additional","affiliation":[]},{"given":"M\u00f3nica","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Jorge","family":"Pol\u00f3nia","sequence":"additional","affiliation":[]},{"given":"Am\u00edlcar","family":"Falc\u00e3o","sequence":"additional","affiliation":[]},{"given":"Adolfo","family":"Figueiras","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2012,12,13]]},"reference":[{"issue":"7\u20138","key":"1962_CR1","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1177\/106002809302700702","volume":"27","author":"T.R. Einarson","year":"1993","unstructured":"Einarson TR. Drug-related hospital admissions. Ann Pharmacother 1993; 27(7\u20138): 832\u201340","journal-title":"Ann Pharmacother"},{"issue":"15","key":"1962_CR2","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","volume":"279","author":"J. Lazarou","year":"1998","unstructured":"Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279(15): 1200\u20135","journal-title":"JAMA"},{"issue":"7456","key":"1962_CR3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","volume":"329","author":"M. Pirmohamed","year":"2004","unstructured":"Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004; 329(7456): 15\u20139","journal-title":"BMJ"},{"issue":"17","key":"1962_CR4","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1001\/jama.287.17.2215","volume":"287","author":"K.E. Lasser","year":"2002","unstructured":"Lasser KE, Allen PD, Woolhandler SJ, et al. Timing of new black box warnings and withdrawals for prescription medications. JAMA 2002; 287(17): 2215\u201320","journal-title":"JAMA"},{"issue":"1","key":"1962_CR5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2165\/00002018-200932010-00007","volume":"32","author":"C. Pedros","year":"2009","unstructured":"Pedros C, Vallano A, Cereza G, et al. An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain. Drug Saf 2009; 32(1): 77\u201383","journal-title":"Drug Saf"},{"issue":"5","key":"1962_CR6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","volume":"29","author":"L. Hazell","year":"2006","unstructured":"Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf 2006; 29(5): 385\u201396","journal-title":"Drug Saf"},{"issue":"9","key":"1962_CR7","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2165\/00002018-200528090-00007","volume":"28","author":"M.T. Herdeiro","year":"2005","unstructured":"Herdeiro MT, Figueiras A, Polonia J, et al. Physicians\u2019 attitudes and adverse drug reaction reporting: a case-control study in Portugal. Drug Saf 2005; 28(9): 825\u201333","journal-title":"Drug Saf"},{"key":"1962_CR8","first-page":"17","volume-title":"Epidemiological issues in reported drug-induced illnesses","author":"W.H.W. Inman","year":"1976","unstructured":"Inman WHW. Assessment drug safety problems. In: Gent M, Shigmatsu I, editors. Epidemiological issues in reported drug-induced illnesses. Honolulu, Ontario: McMaster University Library Press, 1976: 17\u201324"},{"issue":"4","key":"1962_CR9","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2125.1996.tb00004.x","volume":"42","author":"C.C. Smith","year":"1996","unstructured":"Smith CC, Bennett PM, Pearce HM, et al. Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines. Br J Clin Pharmacol 1996; 42(4): 423\u20139","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"1962_CR10","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2165\/00002018-200629040-00004","volume":"29","author":"M.T. Herdeiro","year":"2006","unstructured":"Herdeiro MT, Figueiras A, Polonia J, et al. Influence of pharmacists\u2019 attitudes on adverse drug reaction reporting: a case-control study in Portugal. Drug Saf 2006; 29(4): 331\u201340","journal-title":"Drug Saf"},{"issue":"4","key":"1962_CR11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2753.2003.00456.x","volume":"10","author":"M.T. Herdeiro","year":"2004","unstructured":"Herdeiro MT, Polonia J, Gestal-Otero JJ, et al. Factors that influence spontaneous reporting of adverse drug reactions: a model centralized in the medical professional. J Eval Clin Pract 2004; 10(4): 483\u20139","journal-title":"J Eval Clin Pract"},{"issue":"1","key":"1962_CR12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00002018-200932010-00002","volume":"32","author":"E. Lopez-Gonzalez","year":"2009","unstructured":"Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Saf 2009; 32(1): 19\u201331","journal-title":"Drug Saf"},{"issue":"9","key":"1962_CR13","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1001\/jama.296.9.1086","volume":"296","author":"A. Figueiras","year":"2006","unstructured":"Figueiras A, Herdeiro MT, Polonia J, et al. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. JAMA 2006; 296(9): 1086\u201393","journal-title":"JAMA"},{"key":"1962_CR14","unstructured":"World Health Organization, The Uppsala Monitoring Centre. Glossary of terms used in pharmacovigilance [online]. Available from URL: http:\/\/www.who-umc.org\/graphics\/25301.pdf [Accessed 2011 Feb 9]"},{"issue":"7211","key":"1962_CR15","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","volume":"319","author":"S. Hollis","year":"1999","unstructured":"Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 1999; 319(7211): 670\u20134","journal-title":"BMJ"},{"key":"1962_CR16","volume-title":"Mixed-effects models in S and S-PLUS","author":"J.C. Pinheiro","year":"2006","unstructured":"Pinheiro JC, Bates DM. Mixed-effects models in S and S-PLUS. 3rd ed. New York: Springer, 2006","edition":"3"},{"issue":"11","key":"1962_CR17","first-page":"2300","volume":"46","author":"T.E. Vorcewest","year":"1989","unstructured":"Vorcewest TE, Barstow L, Butcher B. System for voluntary reporting of adverse drug-reactions in a university hospital. Am J Hosp Pharm 1989; 46(11): 2300\u20133","journal-title":"Am J Hosp Pharm"},{"issue":"4","key":"1962_CR18","first-page":"259","volume":"22","author":"C. Sivaram","year":"1996","unstructured":"Sivaram C, Johnson S, Tirmizi SN, et al. Morning report: a forum for reporting adverse drug reactions. Jt Comm J Qual Improv 1996; 22(4): 259\u201363","journal-title":"Jt Comm J Qual Improv"},{"issue":"14","key":"1962_CR19","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2165\/00002018-200326140-00005","volume":"26","author":"J.M. Castel","year":"2003","unstructured":"Castel JM, Figueras A, Pedros C, et al. Stimulating adverse drug reaction reporting: effect of a drug safety bulletin and of including yellow cards in prescription pads. Drug Saf 2003; 26(14): 1049\u201355","journal-title":"Drug Saf"},{"key":"1962_CR20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1046\/j.1365-2125.1997.00616.x","volume":"44","author":"P. McGettigan","year":"1997","unstructured":"McGettigan P, Golden J, Conroy RM, et al. Reporting of adverse drug reactions by hospital doctors and the response to intervention. Br J Clin Pharmacol 1997; 44: 98\u2013100","journal-title":"Br J Clin Pharmacol"},{"key":"1962_CR21","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00228-005-0072-0","volume":"62","author":"M. Backstrom","year":"2006","unstructured":"Backstrom M, Mjorndal T. A small economic inducement to stimulate increased reporting of adverse drug reactions: a way of dealing with an old problem? Eur J Clin Pharmacol 2006; 62: 381\u20135","journal-title":"Eur J Clin Pharmacol"},{"key":"1962_CR22","first-page":"1327","volume":"47","author":"G.W. Gilroy","year":"1990","unstructured":"Gilroy GW, Scollins MJ, Gay CA, et al. Pharmacy-coordinated program that encourages physician reporting of adverse drug reactions. Am J Hosp Pharm 1990; 47: 1327\u201333","journal-title":"Am J Hosp Pharm"},{"issue":"5","key":"1962_CR23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2165\/11319170-000000000-00000","volume":"33","author":"M. Gony","year":"2010","unstructured":"Gony M, Badie K, Sommet A, et al. Improving adverse drug reaction reporting in hospitals: results of the French Pharmacovigilance in Midi-Pyrenees region (Pharmaco-MIP) network 2-year pilot study. Drug Saf 2010; 33(5): 409\u201316","journal-title":"Drug Saf"},{"issue":"13","key":"1962_CR24","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1001\/jama.1990.03440130073028","volume":"263","author":"H.D. Scott","year":"1990","unstructured":"Scott HD, Thacher-Renshaw A, Rosenbaum SE, et al. Physician reporting of adverse drug reactions: results of the Rhode Island adverse drug reaction reporting project. JAMA 1990; 263(13): 1785\u20138","journal-title":"JAMA"},{"key":"1962_CR25","doi-asserted-by":"crossref","unstructured":"Thomson O\u2019Brien MA, Freemantle N, Oxman AD, et al. Continuing education meetings and workshops: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2001: (2): CD003030","DOI":"10.1002\/14651858.CD003030"},{"issue":"9","key":"1962_CR26","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/jama.282.9.867","volume":"282","author":"D. Davis","year":"1999","unstructured":"Davis D, O\u2019Brien MA, Freemantle N, et al. Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes?. JAMA 1999; 282(9): 867\u201374","journal-title":"JAMA"},{"issue":"9","key":"1962_CR27","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/jama.1995.03530090032018","volume":"274","author":"D. Davis","year":"1995","unstructured":"Davis D, Thomson M, Oxman A, et al. Changing physicians performance: a systematic review of the effect of continuing medical education strategies. JAMA 1995; 274(9): 700\u20135","journal-title":"JAMA"},{"key":"1962_CR28","unstructured":"Thomson O\u2019Brien MA, Oxman AD, Davis DA, et al. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2000; (2): CD000409"},{"issue":"2","key":"1962_CR29","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00005650-200102000-00006","volume":"39","author":"A. Figueiras","year":"2001","unstructured":"Figueiras A, Sastre I, Tato F, et al. One-to-one versus group sessions to improve prescription in primary care: a pragmatic randomized controlled trial. Med Care 2001; 39(2): 158\u201367","journal-title":"Med Care"},{"issue":"1","key":"1962_CR30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1590\/S0034-89102010005000050","volume":"45","author":"I. Ribeiro-Vaz","year":"2010","unstructured":"Ribeiro-Vaz I, Herdeiro MT, Polonia J, et al. Strategies to increase the sensitivity of pharmacovigilance in Portugal. Rev Saude Publica 2010; 45(1): 129\u201335","journal-title":"Rev Saude Publica"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03261962.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03261962\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03261962","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,7]],"date-time":"2019-07-07T21:46:01Z","timestamp":1562535961000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03261962"}},"subtitle":["A Cluster-Randomized Trial in Portugal"],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["1962"],"URL":"https:\/\/doi.org\/10.1007\/bf03261962","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}